Analytik Jena Takes 20 Percent Stake in Westburg | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Analytik Jena has acquired 20 percent of the shares of its Dutch distribution partner, Westburg, for €150,000 ($215,272).

Based in Leusden, The Netherlands, Westburg specializes in molecular diagnostics sales and distribution. Its primary markets are the Benelux and Scandinavian countries.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.